Tumor lysis syndrome following cabazitaxel administration for metastatic castration‐resistant prostate cancer: A case report

INTRODUCTION: Tumor lysis syndrome is a rare and potentially fatal complication of oncological treatment. It is characterized by biochemical changes associated with the rapid lysis of malignant cells, usually after chemotherapy. Tumor lysis syndrome is typically noted in patients with hematological...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshima, Masashi, Mayumi, Shozaburou, Yazaki, Kai, Nakamura, Yuuki, Konishi, Tsuzumi, Saito, Kimitoshi, Washino, Satoshi, Miyagawa, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292075/
https://www.ncbi.nlm.nih.gov/pubmed/32743405
http://dx.doi.org/10.1002/iju5.12070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292075/
https://www.ncbi.nlm.nih.gov/pubmed/32743405
http://dx.doi.org/10.1002/iju5.12070

Ejemplares similares